Why the Oxygen Concentrators Market Is Gaining Momentum in 2025
In 2025, the oxygen concentrators market stands at the intersection of healthcare innovation and rising respiratory health concerns. As chronic obstructive pulmonary disease (COPD), asthma, and post-COVID lung damage continue to rise globally, demand for reliable, efficient oxygen delivery systems has never been higher.
With the global market projected to grow from USD 1.27 billion in 2025 to USD 1.71 billion by 2030 at a CAGR of 6.1%, oxygen concentrators are becoming a cornerstone of both hospital-based respiratory care and home healthcare ecosystems. Their increasing role in digital health, remote monitoring, and non-invasive therapy underscores their importance in modern patient management.
Latest Developments (2024–2025): Innovation Driving Accessibility and Efficiency
The past two years have been transformative for oxygen therapy technologies, with leading companies launching next-generation concentrators designed for better mobility, accuracy, and patient convenience.
-
June 2025: Inogen, Inc. launched the Voxi 5 Stationary Oxygen Concentrator, a cost-effective, durable system aimed at improving long-term care oxygen therapy access in the US.
-
October 2024: Inogen introduced the Rove 4 Portable Oxygen Concentrator (POC) — featuring Intelligent Delivery Technology³, which detects a user’s breath within 250 milliseconds to deliver oxygen precisely when it’s most needed.
-
Koninklijke Philips N.V. continued integrating real-time monitoring and smart connectivity in its concentrators to enhance remote patient management and caregiver efficiency.
These developments mark a shift toward connected, portable, and patient-centered oxygen therapy, bridging hospital-grade care with the comfort of home.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=199087330
Market Overview & Key Insights
The oxygen concentrators market is expanding rapidly due to increasing respiratory disease prevalence, aging populations, and advancements in portable medical devices. COPD alone affects over 300 million people worldwide, ranking as the third leading cause of death globally.
Key growth factors include:
-
Rising incidence of COPD, asthma, and post-COVID lung conditions
-
Increasing adoption of home healthcare solutions
-
Technological innovations improving battery life, noise reduction, and oxygen efficiency
-
Growing awareness of early respiratory care and telehealth-based therapy
Top market players:
-
Koninklijke Philips N.V. (Netherlands)
-
Inogen, Inc. (US)
-
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China)
-
TEIJIN LIMITED (Japan)
-
DAIKIN INDUSTRIES, Ltd. (Japan)
-
ESAB Corporation (Switzerland)
-
Caire, Inc. (US)
-
Drive DeVilbiss Healthcare (US)
The market is highly consolidated, with major players collectively controlling over 70% of global share in 2024. However, emerging manufacturers in Asia-Pacific and Latin America are introducing low-cost, energy-efficient concentrators, intensifying competition.
Regional Analysis
North America
Dominates the market due to advanced respiratory care infrastructure, favorable reimbursement systems, and a high burden of chronic respiratory diseases. The US leads in home-based oxygen therapy adoption and device innovation.
Europe
Focuses on clinical quality and regulatory compliance (MDR, CE marking). Germany, the UK, and France continue investing in smart respiratory monitoring systems and integrated care platforms.
Asia-Pacific
Witnessing the fastest growth, supported by government healthcare reforms, local manufacturing initiatives, and rising pollution-related respiratory disorders. China, India, and Japan are key markets for portable concentrators.
Latin America
Countries like Brazil and Mexico are expanding public healthcare investments and oxygen infrastructure post-pandemic, creating new market opportunities for affordable concentrators.
Middle East & Africa
Gradual adoption is driven by growing private healthcare investment, telehealth initiatives, and public awareness programs targeting respiratory wellness.
Technology Drivers & Opportunities
The oxygen concentrators industry is evolving through smart and connected technologies, with digital health integration shaping future designs.
-
AI & IoT Integration: Enables predictive maintenance, automated oxygen flow adjustments, and remote performance tracking.
-
Wearable Oxygen Devices: Compact, battery-efficient models enhance patient mobility and independence.
-
Cloud Connectivity: Real-time data sharing improves doctor-patient communication and remote therapy adjustments.
-
Sustainable Designs: Eco-friendly and energy-efficient concentrators meet global environmental standards.
Opportunities abound in home healthcare, rural telemedicine, and AI-based respiratory analytics, offering new revenue channels for MedTech innovators.
Challenges & Barriers
Despite strong growth, the market faces hurdles including:
-
High device costs and limited insurance coverage in developing regions.
-
Energy dependence of portable models limiting usability in low-resource settings.
-
Lack of awareness regarding device maintenance and calibration.
-
Regulatory and distribution complexities across emerging markets.
Addressing these barriers through affordable manufacturing, training programs, and policy support will be crucial for long-term sustainability.
Future Outlook (2025–2030)
The future of oxygen therapy lies in intelligent, hybrid oxygen systems — combining AI-based oxygen dosing, wireless connectivity, and portable design.
From hospitals to homes, the emphasis will be on non-invasive respiratory care, personalized therapy, and continuous monitoring. By 2030, expect to see:
-
Smart concentrators integrated with mobile health apps.
-
Disposable filters and modular parts improving infection control.
-
Collaborations between respiratory device makers and digital health firms.
Companies like Philips, Inogen, and Drive DeVilbiss Healthcare are expected to lead this digital respiratory revolution through innovation and strategic partnerships.
Lead Generation & Business Opportunities
For medical device manufacturers, healthcare startups, and investors, the oxygen concentrators market offers opportunities in:
-
AI-enabled respiratory monitoring solutions
-
Low-cost concentrator production for emerging markets
-
Cloud-based device management platforms
-
Partnerships with home healthcare providers
As the world embraces home-based care and telemedicine, investing in smart oxygen concentrator technologies promises high growth potential and global impact.
Key Takeaways
-
The oxygen concentrators market is projected to hit USD 1.71 billion by 2030, growing at 6.1% CAGR.
-
Rising respiratory diseases and home healthcare demand are driving adoption.
-
Philips and Inogen lead the market through innovation and connectivity.
-
AI, IoT, and portable design will define the next decade of oxygen therapy.
-
Opportunities exist in affordable, smart, and sustainable concentrator solutions.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=199087330